| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
0.026 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.9 |
| mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.9 |